Pharmacovigilance is one of the areas of the pharmaceutical industry with the most entry opportunities, even for people without manufacturing or laboratory experience. Understanding how to work in pharmacovigilance means first understanding how the system is organised: who collects adverse reaction reports, who assesses them, who answers to the authorities and which professional roles are needed at every point of the chain. In this guide we look at the real roles that make up a pharmacovigilance system, the regulatory requirements that define them and concrete paths to enter the field.
How to work in pharmacovigilance: what the job actually involves
Pharmacovigilance is the set of activities used to identify, assess and prevent adverse reactions to medicinal products after marketing authorisation. It is not "filing work": it is a continuous process that feeds regulatory decisions, label changes and, in the most serious cases, market withdrawals. The daily activities of a pharmacovigilance team include:
- collecting and managing Individual Case Safety Reports (ICSRs), i.e. suspected adverse reaction reports from healthcare professionals, patients and the literature;
- systematic monitoring of the scientific literature;
- signal management: analysing aggregate data to identify new risks or changes in the frequency of known risks;
- preparing periodic safety update reports (PSURs) and risk management plans (RMPs);
- maintaining the Pharmacovigilance System Master File (PSMF) and preparing for audits and inspections.
Each of these activities corresponds to distinct professional roles with different seniority levels: this is what makes the field accessible to junior profiles too.
The regulatory framework: GVP, EMA and national authorities
The European pharmacovigilance system rests on a precise legal framework: Directive 2010/84/EU (which amended Directive 2001/83/EC), Regulation (EU) No 1235/2010 (which amended Regulation (EC) No 726/2004) and Commission Implementing Regulation (EU) No 520/2012, which defines the operational content, from the PSMF to reporting requirements. At the operational level, the daily reference for anyone working in the field is the set of Good Pharmacovigilance Practices (GVP) published by EMA: a series of modules covering pharmacovigilance systems (Module I), the PSMF (Module II), the management of adverse reaction reports (Module VI) and the other key activities. In Italy the competent authority is AIFA, which runs the National Pharmacovigilance Network (RNF) and conducts pharmacovigilance inspections of marketing authorisation holders.
A point often overlooked by people trying to enter the field: studying the GVP modules is free, and in an interview it makes an enormous difference to cite the relevant module correctly instead of talking generically about "the regulations".
If you work in pharmaceutical quality or want to get into it, every week we curate regulatory news and practical tips like these in The Pragmatic GMP, our free newsletter: a simple way to stay current on GVP, GMP and inspections without monitoring ten different sources.
Pharmacovigilance roles: from entry level to QPPV
A company pharmacovigilance system is a pyramid of responsibilities. This table summarises the main roles and typical requirements:
| Role | What they do | Typical requirements |
|---|---|---|
| Drug Safety / PV Specialist (case processing) | Enters, codes (MedDRA) and assesses ICSRs; manages follow-ups and submission deadlines | Science degree (Pharmacy, Pharmaceutical Chemistry, Biology, Nursing); the most common entry role |
| Literature & Signal Specialist | Monitors the literature, contributes to signal management and aggregate data | Case processing experience, data analysis skills |
| PV Writer / Aggregate Reports | Writes PSURs, RMPs and responses to authorities | Excellent regulatory writing in English, GVP knowledge |
| PV Auditor / Compliance | Audits the system, vendors and inspection readiness | Seniority in PV or QA, in-depth knowledge of GVP and the PSMF |
| QPPV (EU-QPPV) | Qualified person responsible for the marketing authorisation holder's entire pharmacovigilance system | Appointed under Art. 104 of Directive 2001/83/EC; sufficient authority over the system, availability and defined back-up |
| Local Pharmacovigilance Officer (RLFV, Italy) | Manages reports within healthcare facilities and enters them into the Italian network (RNF) within 7 days | Appointed by the healthcare facility under Art. 22 of the Italian Ministerial Decree of 30 April 2015, with adequate pharmacovigilance experience |
Be careful not to confuse the two "top" figures: the QPPV works for the marketing authorisation holder and is a single person for the whole company system at European level, with the PSMF required to be continuously accessible to them; the RLFV instead works within national health service facilities (local health units, hospitals, research hospitals) as the local contact point for the authority. They are two different career paths, with different employers.
Requirements and skills to get in
There is no pharmacovigilance professional register: requirements are set by law for the top roles and by the market for everyone else. The skills companies actually look for in junior profiles are:
- A solid scientific foundation: the most sought-after degrees are Pharmacy, Pharmaceutical Chemistry, Biology, Biotechnology, Medicine and Nursing, because you need to understand pharmacology and clinical terminology.
- Professional-level written English: ICSRs, PSURs and correspondence with authorities are almost always written in English.
- Working knowledge of GVP: at least Modules I, II and VI, plus the logic of EudraVigilance and MedDRA coding.
- Documentation accuracy: pharmacovigilance is an inspectable activity; every case must be traceable, complete and handled within the required timelines.
- Deadline-driven mindset: reporting timelines are legal obligations, not internal targets.
How to get in: concrete paths
The most frequent entry routes are three. The first is case processing at CROs and pharmacovigilance service providers, which regularly hire junior profiles to train: the classic training ground. The second is an internship or postgraduate programme in pharmacovigilance and regulatory affairs, often with an in-company project: especially useful for those coming from less sector-specific degrees. The third is an internal move from related roles (medical science liaison, regulatory, quality, clinical operations), leveraging knowledge of company processes. In all three cases, demonstrating knowledge of GVP and EudraVigilance before the interview is the fastest way to stand out.
GuideGxP recommendation
Anyone aiming to grow in pharmacovigilance should build three habits from day one: read the GVP modules in their current version (not the summaries), follow the EMA and national authority pages on pharmacovigilance and inspections, and keep an up-to-date personal map of reporting flows and deadlines. Career-wise, it also pays to understand early how the PSMF works: it is the document that "photographs" the entire system, and it is the ground on which audits and inspections are played out.
If you want a complete operational reference, our guide QPPV and the Pharmacovigilance System — Operational Guide for the QPPV and their team covers the obligations, responsibilities and documents of the pharmacovigilance system with a ready-to-use toolkit: useful both for those already working in the field and for those who want to arrive prepared for senior roles.
